• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全甲状腺切除术联合放射性碘治疗甲状腺癌的临床疗效及其对患者生活质量的影响

Clinical Treatment Efficacy of Total Thyroidectomy Combined with Radioactive Iodine on Treatment of Thyroid Cancer and Its Effect on the Quality of Life of Patients.

作者信息

Yang Yong, Jiao Yanqin, Yu Jieqing, Wang Chenxiu

机构信息

Department of Vascular Mammary Surgery (Thyroid and Hernia), Jiangxi Provincial People's Hospital, Nanchang University, Nanchang, 330006, P.R. China.

Department of Nursing, Jiangxi Health Vocational College, Nanchang, 330052, P.R. China.

出版信息

Iran J Public Health. 2019 Aug;48(8):1461-1468.

PMID:32292729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7145917/
Abstract

BACKGROUND

To investigate the treatment efficacy of radioactive iodine therapy on patients after total thyroidectomy and its effect on the quality of life.

METHODS

A retrospective analysis of clinical data of 120 thyroid cancer patients admitted to Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China from February 2014 to February 2017 was performed. According to different treatment methods, they were divided into observation group of 62 cases and control group of 58 cases. Both groups were treated with total thyroidectomy. The control group was treated with anti-infection and prevention of complications after operation, the observation group with radioactive iodine therapy. Treatment efficacy, quality of life score, recurrent laryngeal nerve injury and postoperative survival rate were compared between the two groups.

RESULTS

The total effective rate of treatment in the test group was 98.39%, significantly higher than 72.41% in the control group, with a statistically significant difference (<0.05). Compared with the control group, the fatigue score of the test group was lower, but the score in the area of emotion function and the overall health status score were higher, with a statistically significant difference (<0.05). There was no significant difference in the recurrent laryngeal nerve injury between the two groups of patients. The postoperative survival rate of the test group of patients was 96.77%, significantly higher than 86.21% of the control group.

CONCLUSION

The effect of radioactive iodine therapy after total thyroidectomy is remarkable, which can significantly improve the clinical treatment efficacy and postoperative quality of life of patients, worthy of clinical application.

摘要

背景

探讨放射性碘治疗对全甲状腺切除术后患者的治疗效果及其对生活质量的影响。

方法

对2014年2月至2017年2月在中国南昌大学附属江西省人民医院收治的120例甲状腺癌患者的临床资料进行回顾性分析。根据不同治疗方法,将其分为观察组62例和对照组58例。两组均行全甲状腺切除术。对照组术后给予抗感染及预防并发症治疗,观察组给予放射性碘治疗。比较两组的治疗效果、生活质量评分、喉返神经损伤情况及术后生存率。

结果

试验组治疗总有效率为98.39%,显著高于对照组的72.41%,差异有统计学意义(<0.05)。与对照组相比,试验组疲劳评分较低,但情绪功能领域评分及总体健康状况评分较高,差异有统计学意义(<0.05)。两组患者喉返神经损伤情况差异无统计学意义。试验组患者术后生存率为96.77%,显著高于对照组的86.21%。

结论

全甲状腺切除术后放射性碘治疗效果显著,可显著提高患者的临床治疗效果及术后生活质量,值得临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/7145917/1503ec4e99f1/IJPH-48-1461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/7145917/1503ec4e99f1/IJPH-48-1461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/7145917/1503ec4e99f1/IJPH-48-1461-g001.jpg

相似文献

1
Clinical Treatment Efficacy of Total Thyroidectomy Combined with Radioactive Iodine on Treatment of Thyroid Cancer and Its Effect on the Quality of Life of Patients.全甲状腺切除术联合放射性碘治疗甲状腺癌的临床疗效及其对患者生活质量的影响
Iran J Public Health. 2019 Aug;48(8):1461-1468.
2
Clinical effect of total thyroidectomy combined with radioactive iodine in thyroid cancer treatment.
Pak J Pharm Sci. 2018 Jul;31(4(Special)):1675-1678.
3
Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.放射性碘对 2 厘米以下侵袭性甲状腺乳头状癌变异型患者的总生存率无改善。
Surgery. 2022 Jan;171(1):203-211. doi: 10.1016/j.surg.2021.05.054. Epub 2021 Aug 10.
4
Total or Near-total Thyroidectomy in treatment of Thyroid Cancer.全甲状腺切除术或近全甲状腺切除术治疗甲状腺癌
Pak J Med Sci. 2022 Jul-Aug;38(6):1662-1667. doi: 10.12669/pjms.38.6.5765.
5
Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after Surgery.碘-131联合左甲状腺素钠在分化型甲状腺癌术后患者中的应用价值
Oncology. 2025;103(5):360-368. doi: 10.1159/000541546. Epub 2024 Sep 20.
6
Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.应用美国甲状腺协会的新指南导致甲状腺全切术的完成率大幅提高,以便进行辅助放射性碘治疗。
Surgery. 2017 Jan;161(1):127-133. doi: 10.1016/j.surg.2016.05.056. Epub 2016 Nov 14.
7
Does the radioactive iodine dose affect smell, taste sensation and nose function?放射性碘剂量会影响嗅觉、味觉和鼻子功能吗?
J Laryngol Otol. 2021 Jan;135(1):50-56. doi: 10.1017/S0022215120002571. Epub 2021 Jan 22.
8
Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.甲状腺微小乳头状癌患者的生活质量:甲状腺全切除术联合或不联合放射性碘消融治疗。
Endocrinol Metab (Seoul). 2020 Mar;35(1):115-121. doi: 10.3803/EnM.2020.35.1.115.
9
[A comparative study of endoscopic and traditional open surgery in the treatment of papillary thyroid carcinoma].[内镜手术与传统开放手术治疗甲状腺乳头状癌的对比研究]
Zhonghua Wai Ke Za Zhi. 2018 Feb 1;56(2):135-138. doi: 10.3760/cma.j.issn.0529-5815.2018.02.011.
10
The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter.在良性结节性甲状腺肿中,近全甲状腺切除术对于避免术后甲状旁腺功能减退的优势。
Langenbecks Arch Surg. 2006 Nov;391(6):567-73. doi: 10.1007/s00423-006-0091-z. Epub 2006 Sep 21.

引用本文的文献

1
Role of Prehabilitation and Rehabilitation on Functional Recovery and Quality of Life in Thyroid Cancer Patients: A Comprehensive Review.术前康复和康复对甲状腺癌患者功能恢复和生活质量的作用:一项综述
Cancers (Basel). 2023 Sep 10;15(18):4502. doi: 10.3390/cancers15184502.

本文引用的文献

1
Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: a case report.甲状腺全切除及放射性碘消融术后43年甲状腺乳头状癌复发:一例报告
Thyroid Res. 2017 Oct 10;10:8. doi: 10.1186/s13044-017-0043-4. eCollection 2017.
2
Quality-of-life outcomes in Graves disease patients after total thyroidectomy.
Ear Nose Throat J. 2017 Apr-May;96(4-5):E8-E15. doi: 10.1177/0145561317096004-501.
3
Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study.临床淋巴结阴性分化型甲状腺癌单纯全甲状腺切除术与同侧及双侧预防性中央区颈淋巴结清扫术的比较:一项回顾性多中心研究
Eur J Surg Oncol. 2017 Jan;43(1):126-132. doi: 10.1016/j.ejso.2016.09.017. Epub 2016 Oct 13.
4
Predictors and risk factors of hypoparathyroidism after total thyroidectomy.甲状腺全切除术后甲状旁腺功能减退症的预测因素和危险因素。
Int J Surg. 2016 Oct;34:47-52. doi: 10.1016/j.ijsu.2016.08.019. Epub 2016 Aug 20.
5
Diminished Quality of Life and Increased Brain Functional Connectivity in Patients with Hypothyroidism After Total Thyroidectomy.全甲状腺切除术后甲状腺功能减退患者的生活质量下降及脑功能连接增加
Thyroid. 2016 May;26(5):641-9. doi: 10.1089/thy.2015.0452. Epub 2016 Apr 11.
6
Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis.半乳糖凝集素-3可能作为甲状腺乳头状癌诊断和预后的潜在标志物:一项荟萃分析。
Onco Targets Ther. 2016 Jan 22;9:455-60. doi: 10.2147/OTT.S94514. eCollection 2016.
7
Primary tumour characteristics predict the invasiveness of lymph node metastases in papillary thyroid carcinoma patients.原发性肿瘤特征可预测甲状腺乳头状癌患者淋巴结转移的侵袭性。
J Laryngol Otol. 2016 Mar;130(3):302-8. doi: 10.1017/S0022215115003382. Epub 2015 Dec 16.
8
Total versus bilateral subtotal thyroidectomy for benign multi-nodular goiter.全甲状腺切除术与双侧次全甲状腺切除术治疗良性多结节性甲状腺肿
Int J Clin Exp Med. 2015 Mar 15;8(3):4596-600. eCollection 2015.
9
Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation.全甲状腺切除及放射性碘消融术后分化型甲状腺癌延迟风险分层的优势
Nucl Med Commun. 2014 Nov;35(11):1119-26. doi: 10.1097/MNM.0000000000000183.
10
[Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma].[重组人促甲状腺素在分化型甲状腺癌随访患者中的应用评估]
Vojnosanit Pregl. 2012 Nov;69(11):941-6. doi: 10.2298/vsp1211941r.